Status:
TERMINATED
Efficacy and Safety of Homeopathy for Moderate Depression (Acute Phase)
Lead Sponsor:
Charite University, Berlin, Germany
Conditions:
Major Depression
Eligibility:
All Genders
18-65 years
Phase:
PHASE3
Brief Summary
To assess the two components of individualized homeopathic treatment for acute depression, i.e., to investigate the specific effect of individualized Q-potencies versus placebo and to investigate the ...
Detailed Description
Homeopathy is often sought by patients with depression. In classical homeopathy, the treatment consists of two main elements: the taking of the case history and the prescription of an individually sel...
Eligibility Criteria
Inclusion
- diagnosis of major depression by a psychiatrist,
- patients must not be currently taking antidepressants or anxiolytic drugs (with the exception of Lorazepam as rescue medication, maximal dose 1.5 mg/day)
- Capability and willingness to give informed consent and to comply with the study procedures will also be required
Exclusion
- current mild episode of depression (HAM-D \< 17)
- current severe episode of depression (HAM-D \> 24)
- schizophrenia or other psychotic disorders
- bipolar affective disorder
- schizoaffective disorders
- alcohol or other substance abuse
- eating disorders
- a clinically significant (Diagnostic and Statistical Manual of Mental Disorders)-Axis II disorder
- severe depression, which previously motivated a suicide attempt
- a score of 4 or 5 in the Columbia-Suicide Severity Rating Scale (C-SSRS)up to three months before screening;
- a clinically significant acute or chronic disease that would hinder regular participation in the study
- treatment with antipsychotics, antidepressants, sedatives/hypnotics or mood stabilizers four weeks prior to the screening
- complementary or alternative treatment simultaneously to the study (for example, acupuncture, phytotherapy, etc.)
- homeopathic treatment eight weeks prior to study entry
- psychotherapy
- simultaneous participation in another clinical trial (the last participation in a previous clinical trial must be completed at least three months prior to screening)
- concomitant pregnancy or breastfeeding
- patients who are assumed to have a linguistic, intellectual or any other reason for not understanding the meaning of the clinical trial and for not complying with the necessary study procedures
- persons who have been institutionalized by a court order
- patients with an application for a pension
Key Trial Info
Start Date :
August 1 2010
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 1 2011
Estimated Enrollment :
44 Patients enrolled
Trial Details
Trial ID
NCT01178255
Start Date
August 1 2010
End Date
July 1 2011
Last Update
July 10 2012
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Institute for Social Medicine, Epidemiology, and Health Economics, Charité University Medical Center Berlin, Germany
Berlin, State of Berlin, Germany